The tweet was deleted by the author.
But we saved everything 🙂.
Broadcom unveiled AgentMinder, a new solution aimed at overseeing and securing the use of AI-powered digital employees in enterprise environments. Shares edged higher on the day, trading at $371.37.
Broadcom announced AgentMinder, an enterprise solution for AI agent governance and runtime control, at VMware Explore on August 31, 2026. According to GlobeNewswire, AgentMinder enables company-wide deployment of AI agents by providing chain of custody capabilities and achieved massive global scale with zero downtime during maintenance. As reported by StorageReview, AgentMinder provides AI agents with identity, policy, and audit controls as part of an integrated defense architecture for enterprise deployments.
View post on X Loading...
The intraday range in the latest session expanded sharply, stretching from $364.08 to $371.29, well above the average for the week. Broadcom stock remains below the MA-20 and MA-50 but is still holding above the MA-200 at $369.49, creating a split daily structure. The overall move remains muted and fits within the broader bullish chart structure.
A close above $373.95 would indicate buyers are willing to continue higher, while a fall below $369.49 would suggest the move is being faded. During the latest session, price traveled in a wide band between $364.08 and $371.29. The past week saw a contained move within a narrow range, but from here, downside probability is 60% and upside probability is 40% for the coming trading week, with the expected range set between $360.72 and $382.01. On the weekly chart the longer-term picture stays constructive.
Previously it was reported that Broadcom’s launch of VMware Private AI Cloud contributed to downside risks in the near term, despite longer-term constructive trends. The unveiling of AgentMinder further expands Broadcom’s enterprise AI portfolio, and with the stock’s structure remaining split between support and resistance, traders should monitor price stability above the MA-200 at $369.49 for indications of further upside.